Andere talen ImpediMed Limited

Aandelen

Beurs gesloten - Australian S.E. Andere beurzen 07:59:53 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,093 ^AUD	-2,11%		+1,09%	-35,86%

17/04	IMPEDIMED LIMITED : Ord Minnet positief over het aandeel	ZM
11/04	ImpediMed presenteert de resultaten van de studie naar chronisch borstkankergerelateerd lymfoedeem tijdens de jaarlijkse bijeenkomst van de American Society of Breast Surgeons	CI

Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant	17/04
ImpediMed to Present Chronic Breast Cancer-Related Lymphedema Study Results at American Society of Breast Surgeons Annual Meeting	11/04
ImpediMed Limited(ASX:IPD) added to S&P/ASX All Ordinaries Index	18/03
Impedimed Names Independent Non-Executive Chair	27/02
ImpediMed Narrows Loss in Fiscal H1, Revenue Declines; Shares Fall 7%	27/02
ImpediMed Limited Reports Earnings Results for the Half Year Ended December 31, 2023	26/02
ImpediMed Says New Guidelines for Lymphedema Detection Will Help Company Sales	14/02
ImpediMed CEO, CFO Step Down; Shares Fall 11%	20/11
ImpediMed Limited Announces CEO Changes	19/11
ImpediMed Limited Announces CFO Changes	19/11
ImpediMed Limited Announces Management Changes	19/11
ImpediMed Secures Payor Clearance for Spectroscopy Device in the US; Shares Rise 4%	03/11
Morgans rates IPD as Add	01/11
ImpediMed Limited Announces Resignation of Mrs. Janet West AM as Non-Executive Director	03-10-23
Impedimed Limited Announces Board Changes	28-09-23
Declaration of Voting Results by ImpediMed Limited	28-09-23
ImpediMed Appoints Medical Chief; Shares Down 3%	27-09-23
ImpediMed Limited Announce the Appointment of Steven Chen as Chief Medical Officer	27-09-23
Impedimed Widens Fiscal 2023 Loss; Shares Down 3%	31-08-23
ImpediMed Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31-08-23

Geen resultaten voor deze zoekopdracht